—

Hims Hers Health Inc(HIMS)— 同类公司组

数据截至2026-10-08 — 评分每个交易日晚间重新计算。分组标准=首先为共同的Closelook指数成分,其次为行业。Closelook研究日记,不构成投资建议。

Hims Hers Health Inc的Closelook综合评分为37/100,在同类公司组内排名第11位(共11家)——组内评分最高的是Halozyme Therapeutics Inc(74/100)。

名称综合动量质量估值信号距52周高点
HIMS Hims Hers Health Inc37423121info57%
ROVI.MC Laboratorios Farmaceuticos ROVI61277752warn31.8%
LNTH Lantheus Holdings Inc60687457info10.5%
KNSA Kiniksa Pharmaceuticals Ltd57945921ok5.1%
AMRX Amneal Pharmaceuticals, Inc. Class A Common Stock54895842ok7.2%
GALDY GALDERMA GROUP AG54445928info15%
ALM.MC Almirall S.A.53224668warn27.1%
HALO Halozyme Therapeutics Inc74949451ok6%
DXCM DexCom Inc66838037watch9%
ONC BeiGene, Ltd.64776432info9.1%
MEDP Medpace Holdings Inc63827530ok11.1%

评分为Closelook全部覆盖范围内的相对读数——方法论见公司评分说明。信号灯来自每日夜间信号看板。

FAQ · from the current data · as of 2026-10-08

Quick answers

Hims Hers Health Inc在Closelook覆盖范围内的同类公司有哪些?

分组首先基于共同的Closelook指数成分,其次基于行业:Laboratorios Farmaceuticos ROVI (ROVI.MC)、Lantheus Holdings Inc (LNTH)、Kiniksa Pharmaceuticals Ltd (KNSA)、Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX)、GALDERMA GROUP AG (GALDY)、Almirall S.A. (ALM.MC)、Halozyme Therapeutics Inc (HALO)、DexCom Inc (DXCM)等。

HIMS相对同类公司的评分如何?

Hims Hers Health Inc的综合评分为37/100,组内排名第11位(共11家),截至2026-10-08;组内最高综合评分为Halozyme Therapeutics Inc(74/100)。Closelook评分为研究日记读数,不构成评级或投资建议。

Related in the Closelooknet universe

then Drug Manufacturers - Specialty & Generic, then Healthcare. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.